Search details
1.
Design, synthesis and biological evaluation of new RNF126-based p300/CBP degraders.
Bioorg Chem
; 148: 107427, 2024 Jul.
Article
in English
| MEDLINE | ID: mdl-38728911
2.
Design, synthesis and structure-activity relationship study of piperazinone-containing thieno[3,2-d]pyrimidine derivatives as new PI3Kδ inhibitors.
Bioorg Med Chem Lett
; 30(20): 127479, 2020 10 15.
Article
in English
| MEDLINE | ID: mdl-32784091
3.
Identification of a potent and selective phosphatidylinositol 3-kinase δ inhibitor for the treatment of non-Hodgkin's lymphoma.
Bioorg Chem
; 105: 104344, 2020 12.
Article
in English
| MEDLINE | ID: mdl-33091667
4.
Synthesis and antitubercular evaluation of 4-carbonyl piperazine substituted 1,3-benzothiazin-4-one derivatives.
Bioorg Med Chem Lett
; 25(7): 1373-6, 2015 Apr 01.
Article
in English
| MEDLINE | ID: mdl-25754492
5.
Reductions in myeloid-derived suppressor cells and lung metastases using AZD4547 treatment of a metastatic murine breast tumor model.
Cell Physiol Biochem
; 33(3): 633-45, 2014.
Article
in English
| MEDLINE | ID: mdl-24642893
6.
Design, synthesis, and biological evaluation of 4,5-dihydro-[1,2,4]triazolo[4,3-f]pteridine derivatives as novel dual-PLK1/BRD4 inhibitors.
Eur J Med Chem
; 191: 112152, 2020 Apr 01.
Article
in English
| MEDLINE | ID: mdl-32088495
7.
Correction: Inhibition of Stat3 signaling pathway by nifuroxazide improves antitumor immunity and impairs colorectal carcinoma metastasis.
Cell Death Dis
; 10(10): 722, 2019 Sep 26.
Article
in English
| MEDLINE | ID: mdl-31558703
8.
Inhibition of Stat3 signaling pathway by nifuroxazide improves antitumor immunity and impairs colorectal carcinoma metastasis.
Cell Death Dis
; 8(1): e2534, 2017 01 05.
Article
in English
| MEDLINE | ID: mdl-28055016
Results
1 -
8
de 8
1
Next >
>>